The Norwegian Council on Cardiovascular Disease Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
1998
NCT00266487
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

The Norwegian Council for Cardiovascular Diseases.

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

Drugs in Other Trials (3)

cyanocobalamin (berocca) (1 trial)

folic acid (1 trial)

pyridoxine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Atherosclerosis (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Heart Diseases (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5